Provided by Tiger Fintech (Singapore) Pte. Ltd.

Special Opportunities Fund

14.85
+0.0000
Volume:18.84K
Turnover:279.47K
Market Cap:157.83M
PE:4.54
High:14.90
Open:14.84
Low:14.77
Close:14.85
Loading ...

Press Release: Shareholders of Tejon Ranch Co. Urged to Vote for an Accountable Board of Directors

Dow Jones
·
14 hours ago

China's Countertariffs to Hit US Semiconductor, CPU Makers, Boost Local Rivals

MT Newswires Live
·
14 Apr

Special Opportunities Fund Seeks to Elect Directors of Tejon Ranch Co.

THOMSON REUTERS
·
11 Apr

Press Release: Special Opportunities Fund Seeks to Elect Directors of Tejon Ranch Co.

Dow Jones
·
11 Apr

Press Release: Special Opportunities Fund Declares Distributions For Second Quarter of 2025

Dow Jones
·
05 Apr

Special Opportunities Fund, Inc. Dividend Declaration

THOMSON REUTERS
·
14 Mar

Press Release: Special Opportunities Fund, Inc. Dividend Declaration

Dow Jones
·
14 Mar

Savannah Energy Plc Completion of the SIPEC Acquisition

Dow Jones
·
10 Mar

Northern Trust Expands Partnership with Alchemy to Support Its New Special Opportunities Fund

Business Wire
·
18 Feb

US Restrictions Drive December Surge in China's Semiconductor Imports, Jefferies Says

MT Newswires Live
·
21 Jan

Press Release: Special Opportunities Fund Declares Distributions For First Quarter of 2025

Dow Jones
·
07 Jan

China's Semiconductor Equipment Imports Further Weaken in November, Jefferies Says

MT Newswires Live
·
02 Jan

Woodside Simplifies Portfolio and Unlocks Long-Term Value

Business Wire
·
19 Dec 2024

Special Opportunities Fund, Inc. Dividend Declaration

THOMSON REUTERS
·
13 Dec 2024

Press Release: Special Opportunities Fund, Inc. Dividend Declaration

Dow Jones
·
13 Dec 2024

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) shows 51 percent reduction in risk of progression to active multiple myeloma for patients with high-risk smoldering multiple myeloma

PR Newswire
·
09 Dec 2024

Art Cashin, Wall Street veteran for over 60 years, dies at age 83

Reuters
·
03 Dec 2024

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma

PR Newswire
·
08 Nov 2024